证券代码：601606 证券简称：长城军工 公告编号：2025-029 安徽长城军工股份有限公司 股票交易严重异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 安徽长城军工股份有限公司（以下简称"长城军工"或"公司"）股票交易于 2025年6月27日，6月30日，7月1日连续3个交易日内收盘价格涨幅偏离值累计超过20%， 属于《上海证券交易所交易规则》规定的股票交易异常波动情形。 ● 截至2025年7月1日收盘，公司股票连续10个交易日内（2025年6月18日至7月1 日）4次出现《上海证券交易所交易规则》规定的同向异常波动情形，根据《上海证券 交易所交易规则》有关规定，属于股票交易严重异常波动情况。目前，公司股票波动 严重异常，存在市场情绪过热的情形，可能存在非理性炒作，公司股票击鼓传花效应 十分明显，交易风险极大，存在短期大幅下跌的风险。敬请广大投资者理性投资，注 意投资风险。 ● 经公司自查并向控股股东及实际控制人核实，不存在应披露而未披露的重大事 项。公司特别提醒广大投资者，注意二级市场 ...

New Stock Issuance - The new stock "同宇新材" (code: 301630) is listed at an issuance price of 84.00[1] - "信通电子" (code: 001388) has an issuance price of 16.42[1] Rights Issues and Announcements - "济川药业" (code: 600566) has a tender offer period from June 18, 2025, to July 17, 2025[1] - "中程退" (code: 300208) has 13 trading days remaining until the last trading day[1] - "退市锦港" (code: 600190) also has 13 trading days remaining until the last trading day[1] - "恒立退" (code: 000622) has 10 trading days remaining until the last trading day[1] Abnormal Fluctuations - "浙江东日" (code: 600113) reported severe abnormal fluctuations[1] - "汇金股份" (code: 300368) is noted for abnormal fluctuations[3]

Core Viewpoint - The A-share military industry sector is experiencing a rebound, with significant stock price increases observed in several companies, indicating renewed investor interest and confidence in the sector [1] Company Performance - Changcheng Military Industry has seen its stock hit the daily limit up, achieving a remarkable performance of 8 out of 10 trading days with price increases [1] - Other companies such as China Shipbuilding Emergency, Lijun Shares, Sichuan Chuang Electronics, and Jihua Group also experienced stock price surges, with some stocks reaching their daily limit [1] - Zhongke Haixun's stock price increased by over 10%, reflecting positive market sentiment towards military-related stocks [1]

智通财经7月1日电，军工股持续反弹，长城军工午后再度涨停走出10天8板，中船应急、长城电工、四 创电子、利君股份、际华集团、微光股份、康达新材等10余股涨停。 军工股持续反弹 长城军工走出10天8板 ...

Group 1 - The military industry sector experienced a significant rally in the afternoon, with Changcheng Military Industry (601606) hitting the daily limit and reaching a new high [1] - Other companies such as China Shipbuilding Emergency (300527) and Lijun Co., Ltd. (002651) previously reached their limit up, indicating strong market interest [1] - Zhongke Haixun (300810) saw an increase of over 10%, while other companies like Zhongbing Hongjian (000519), Inner Mongolia First Machinery (600967), and China Marine Defense (600764) also showed notable gains [1] Group 2 - There is a noticeable influx of dark pool funds into these stocks, suggesting increased investor confidence and potential for further growth in the military sector [1]

证券代码：601606 证券简称：长城军工 公告编号：2025-028 安徽长城军工股份有限公司 股票交易严重异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 全文内容详见上海证券交易所网站 （www. sse.com.cn）。 重要内容提示： ● 截至2025年6月30日收盘，安徽长城军工股份有限公司（以下简称"长城军工" 或"公司"）股票连续10个交易日内（2025年6月18日至6月30日）收盘价格涨幅偏离 值累计超过100%，根据《上海证券交易所交易规则》有关规定，属于股票交易严重异 常波动情况。目前，公司股票波动严重异常，存在市场情绪过热的情形，可能存在非 理性炒作，公司股票击鼓传花效应十分明显，交易风险极大，存在短期大幅下跌的风 险。敬请广大投资者理性投资，注意投资风险。 ● 经公司自查并向控股股东及实际控制人核实，不存在应披露而未披露的重大事 项。公司特别提醒广大投资者，注意二级市场交易风险。 ● 相关风险提示： 股票短期涨幅严重高于同期行业指数及上证指数涨幅，但公司基本面没有重大变化，也 不存在应披露 ...

Core Viewpoint - Longcheng Military Industry (601606.SH) has experienced significant stock price volatility, with a cumulative increase of over 100% in share price from June 18 to June 30, leading to seven consecutive trading days of price limits [2][4]. Group 1: Stock Performance and Announcements - Longcheng Military Industry announced that its controlling shareholder and actual controller have not planned any major asset restructuring, share issuance, or acquisitions [4]. - The company reported a stock price increase that began on June 18, resulting in a significant upward trend in its stock price [2][3]. - The company has clarified that the recent asset restructuring of its indirect controlling shareholder, China Weapon Equipment Group, does not involve Longcheng Military Industry [4]. Group 2: Financial Performance - Longcheng Military Industry has been in a loss position, reporting a net profit of approximately -360 million yuan for 2024 and -50 million yuan for the first quarter of this year [6]. - The company has indicated that its production and operational activities are normal, with no significant changes affecting stock trading [6]. - The company’s revenue in the equipment manufacturing sector decreased by 8.33% year-on-year due to pricing adjustments based on customer evaluations and increased R&D expenses [7]. Group 3: Market Valuation - As of June 30, the weighted average rolling price-to-earnings (P/E) ratio for industry peers is 293.25 times, while Longcheng Military Industry's P/E ratio is negative due to losses [8]. - The weighted average price-to-book (P/B) ratio for industry peers is 4.76 times, whereas Longcheng Military Industry's P/B ratio stands at 9.69 times, indicating a higher valuation compared to its peers [8].

本文字数：593，阅读时长大约1分钟 2025.06. 30 6月30日晚，长城军工（601606.SH）发布股票交易严重异常波动公告，截至6月30日收盘，公司股票连续10个交易日内收盘价格涨幅偏离值累计超过 100%。目前，公司股票波动严重异常，存在市场情绪过热的情形，可能存在非理性炒作，公司股票击鼓传花效应十分明显，交易风险极大，存在短期 大幅下跌的风险。 证券代码:601606 证券简称:长城军工 -- 2.业绩风险:根据《安徽长城军工股份有限公司2024年年度报告》,2024年归属于 上市公司股东的净利润为-363.277,070.70元,归属于上市公司股东的扣除非经常性损 益的净利润为-377,999,295.21元,公司特别提醒投资者注意业绩风险。《安徽长城军 工股份有限公司2024年年度报告》全文内容详见上海证券交易所网站(www.sse.com. cn）。 公告编号:2025-028 安徽长城军工股份有限公司 股票交易严重异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 截至20 ...

Company Highlights - Hanyu Pharmaceutical expects a net profit of 142 million to 162 million yuan for the first half of 2025, benefiting from increased global market demand and successful product approvals [1] - Taotao Automotive anticipates a net profit growth of 70% to 98% year-on-year for the first half of 2025, driven by enhanced brand influence and improved operational efficiency [2] - Xiaogoods City projects a net profit increase of 13% to 17% for the first half of 2025, attributed to growth in main business revenue and trade fulfillment services [2] - Hongxin Electronics signed contracts totaling 373 million yuan for computing power services through its subsidiaries [3] - Alloy Investment's controlling shareholder will change to Jiuzhou Hengchang, leading to the resumption of trading [3] - Hangzhou High-tech is planning a change in control, with a suspension of trading expected for no more than two trading days [4] - Junpu Intelligent signed a sales framework contract for humanoid robots worth 28.25 million yuan [7] - Lens Technology plans to issue 262 million H-shares globally, with an initial price range set between 17.38 and 18.18 HKD [8] - Saintno Biopharmaceuticals received a drug registration certificate for its product, further enhancing its market competitiveness [12] Investment & Contracts - Shenzhen Energy plans to invest 6.332 billion yuan in upgrading the Mawan Power Plant, aligning with national energy policies [17] - China Railway Construction won a contract worth 3.781 billion yuan for the China-Kyrgyzstan-Uzbekistan railway project [27] - China Railway secured contracts totaling approximately 5.343 billion yuan for the same railway project [28] - Zhongtian Technology's subsidiary won multiple marine energy project contracts totaling about 1.722 billion yuan [29] - Lande Group intends to acquire a 20.1667% stake in Jujia Technology for up to 121 million yuan, enhancing its capabilities in high-performance materials [21][22] Financing & Capital Increase - Yiwei Lithium Energy submitted an application for H-share issuance and listing in Hong Kong [30] - Jiadou Technology plans to issue H-shares and list on the Hong Kong Stock Exchange [30] - Helin Micro-Nano is preparing to issue H-shares for listing in Hong Kong [30] Other Developments - Renfu Pharmaceutical received approval for its midazolam injection in France, with expected annual sales of approximately 33 million USD [31] - Kanghong Pharmaceutical obtained a drug registration certificate for its eye drop product, enhancing its product pipeline in the ophthalmology sector [32]

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen stock markets have announced significant updates, including changes in financing, business performance, and strategic decisions, which may impact investor sentiment and market dynamics [1]. Financing and Restructuring - Guanhao Biological has withdrawn its application for refinancing, leading to the termination of the review process by the Shenzhen Stock Exchange [3]. - Jinhongshun has terminated its major asset restructuring plan due to a lack of consensus among parties involved [6]. - Yuyuan Co. plans to issue bonds not exceeding 40 billion yuan to adjust its debt structure and replenish working capital [23]. Business Performance and Uncertainties - Aored has highlighted significant uncertainties in its computing power leasing services due to heavy asset investment and potential market fluctuations [4]. - Guoyao Modern intends to publicly transfer 51% of its subsidiary Guoyao Hason's shares, as the subsidiary has been underperforming with continuous losses since 2021 [5]. - Chengbang Co. reported that its subsidiary, Xinchun Electronics, has a small business scale and faces intense competition in the semiconductor storage industry, with projected revenues of 111 million yuan and a net profit of 933,800 yuan for 2024 [9]. Stock Market Activity - Alloy Investment announced a change in its controlling shareholder to Jiuzhou Hengchang, with stock trading resuming on July 1 [7]. - Changcheng Military Industry reported significant stock price volatility, with a cumulative increase of over 100% in the last 10 trading days, indicating potential irrational market behavior [8]. Earnings Forecasts - Hanyu Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, recovering from a loss in the previous year, driven by international business growth [12]. - Taotao Vehicle anticipates a net profit increase of 70.34% to 97.81% for the same period, reflecting strong sales performance [13]. - Weichai Heavy Machinery projects a net profit increase of 40% to 60%, benefiting from industry policy support and demand growth [15]. Major Contracts and Projects - China Railway has won contracts for overseas construction projects totaling approximately 5.343 billion yuan [17]. - Zhonggong International has signed a 175 million yuan engineering consulting service contract [18]. - Hezhan Energy has entered into a 177 million yuan contract for the sale of steel-concrete towers [19].